Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ferring Pharmaceuticals
Age
20–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
20 years or older
Has a histological confirmed prostate cancer
Has a screening serum testosterone above 1.5 ng/mL
Has a Eastern Cooperative Oncology Group (ECOG) score of ≤ 2
Has a screening PSA value of ≥2 ng/mL
Has a life expectancy of at least 168 days
You may not be if
Current or previous hormone therapy
Is currently treated with 5-α-reductase inhibitor
Has a history of severe untreated asthma, anaphylactic reactions, or severe urticaria and/or angioedema
Is considered to be a candidate for curative therapy, i.e radical prostatectomy or radiotherapy
Has had cancer within the last five years except prostate cancer and surgically removed basal or squamous cell carcinoma of the skin.
Has a clinically significant disorder (other than prostate cancer) or any other condition , including alcohol or drug abuse, which may interfere with trial participation or which may affect the conclusion of the trial as judged by the investigator
Has received an investigational drug within the last 28 days preceding Screening Visit or longer if considered to possibly influence the outcome of the current trial
